Haresign Consulting Services

Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36

Published

23 July 2026

Source

Alerts and Recalls for Drugs and Medical Devices - All

Imported

23 Jul 2026

Original alert

https://www.gov.uk/drug-device-alerts/c…

Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and 40…

View Original Alert

Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.

About this source

Alerts and Recalls for Drugs and Medical Devices - All

All alerts from this source

Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.

View this week's digest

Back to Safety Alerts

Unlock your Practice Performance Overview

Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.